Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose
    PDF
    Cite
    Share
    Request
    Case Report
    P: 127-129
    December 2018

    Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose

    Arch Epilepsy 2018;24(3):127-129
    1. Department of Neurology, Sakarya University Training and Research Hospital, Adapazarı, Turkey
    2. Department of Neurology, Namık Kemal University Faculty of Medicine, Tekirdağ, Turkey
    No information available.
    No information available
    Received Date: 06.10.2017
    Accepted Date: 13.03.2018
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack of sedative effect. Immediate and sustained-release bupropion forms may trigger seizure activity. In the present article, we report a case of a 30-year-old man presenting with generalized tonic clonic seizures induced by extended-release bupropion. We also emphasized that extended-release bupropion, which is commonly used for smoking cessation therapy, may cause seizure at early term and therapeutic dose.

    Keywords: Extended-release bupropion, seizure, smoking cessation treatment

    References

    2024 ©️ Galenos Publishing House